Nevro Management
Management criteria checks 1/4
Nevro's CEO is Kevin Thornal, appointed in Apr 2023, has a tenure of 1.58 years. total yearly compensation is $11.45M, comprised of 4.5% salary and 95.5% bonuses, including company stock and options. directly owns 0.084% of the company’s shares, worth $142.17K. The average tenure of the management team and the board of directors is 1.7 years and 5.3 years respectively.
Key information
Kevin Thornal
Chief executive officer
US$11.5m
Total compensation
| CEO salary percentage | 4.5% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.08% |
| Management average tenure | 1.7yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Little Excitement Around Nevro Corp.'s (NYSE:NVRO) Revenues As Shares Take 34% Pounding
Aug 11
Nevro: Not Having My Back
Aug 09Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?
Jul 16Nevro Corp. (NYSE:NVRO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
May 01Is Nevro (NYSE:NVRO) Using Debt In A Risky Way?
Feb 25There Is A Reason Nevro Corp.'s (NYSE:NVRO) Price Is Undemanding
Jan 08Is Nevro (NYSE:NVRO) Using Debt In A Risky Way?
Nov 16Nevro: Economic Realities Too Deep To Ignore, Downgrade To Hold
Sep 01Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?
Jul 10Investors Shouldn't Be Too Comfortable With Nevro's (NYSE:NVRO) Robust Earnings
Feb 28Nevro falls to 52-week low; down ~49% over last year
Feb 22Nevro: Treating Patient Back Pains, Causing Shareholder Back Pains
Feb 14Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?
Jan 13Nevro: Opportunity Overshadowed By Weaknesses
Dec 07Boston Scientific drives rival Nevro lower after remarks on neuromodulation
Oct 26Nevro's Senza spinal cord stimulation system for chronic pain gets FDA approval
Oct 13Nevro gets FDA approval for Costa Rica manufacturing operations
Oct 04Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?
Oct 02Nevro: Niche Operator In Neuropathy, Reluctant Hold On Valuation
Sep 07Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?
Jun 17Nevro: FDA Approved Lower Back Pain Relief Without Opiates Or Surgery
Jun 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$69m |
| Jun 30 2024 | n/a | n/a | -US$77m |
| Mar 31 2024 | n/a | n/a | -US$83m |
| Dec 31 2023 | US$11m | US$516k | -US$92m |
Compensation vs Market: Kevin's total compensation ($USD11.45M) is above average for companies of similar size in the US market ($USD1.46M).
Compensation vs Earnings: Insufficient data to compare Kevin's compensation with company performance.
CEO
Kevin Thornal (50 yo)
1.6yrs
Tenure
US$11,453,548
Compensation
Mr. Kevin R. Thornal serves as President & Chief Executive Officer at Nevro Corp. since April 24, 2023 and serves as its Director since May 2023. He joined Nevro Corp. on April 24, 2023. He serves as Acti...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.6yrs | US$11.45m | 0.084% $ 142.2k | |
| Senior VP & CFO | 4.4yrs | US$2.58m | 0.066% $ 112.0k | |
| Senior VP of Corporate Development & Chief Legal Officer | 6.9yrs | US$2.55m | 0.13% $ 221.4k | |
| Senior VP & Chief Commercial Officer | 1.4yrs | US$3.56m | 0.058% $ 98.6k | |
| Senior VP & COO | less than a year | US$2.87m | 0.077% $ 130.9k | |
| Vice President of Investor Relations & Corporate Communications | less than a year | no data | no data | |
| Senior VP & Chief Human Resources Officer | 1.8yrs | no data | no data | |
| Senior VP & Chief Medical Officer | 10.6yrs | no data | no data | |
| VP, General Counsel & Corporate Secretary | no data | no data | no data |
1.7yrs
Average Tenure
50.5yo
Average Age
Experienced Management: NVRO's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.5yrs | US$11.45m | 0.084% $ 142.2k | |
| Independent Director | 3.9yrs | US$242.99k | 0.034% $ 57.8k | |
| Independent Director | 10.2yrs | US$246.99k | 0.072% $ 121.4k | |
| Independent Director | 5.7yrs | US$259.24k | 0.16% $ 278.8k | |
| Non-Executive Chairman of the Board | 5.7yrs | US$1.48m | 0.52% $ 884.6k | |
| Independent Lead Director | 13.7yrs | US$284.99k | 1.27% $ 2.2m | |
| Independent Director | 5.7yrs | US$259.99k | 0.065% $ 109.5k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 4.9yrs | US$252.99k | 0.039% $ 66.8k | |
| Independent Director | 3.1yrs | US$242.99k | 0.062% $ 104.7k |
5.3yrs
Average Tenure
61.5yo
Average Age
Experienced Board: NVRO's board of directors are considered experienced (5.3 years average tenure).